Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00050778
Brief Title: A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

First Submitted : December 19, 2002
First Submitted that Met QC Criteria : December 20, 2002
First Posted : December 23, 2002 (Estimate)

Results First Submitted : November 3, 2008
Results First Submitted that Met QC Criteria : July 13, 2009
Results First Posted : August 25, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : January 6, 2015
Last Update Posted : January 8, 2015 (Estimate)